Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|November 20, 2008
Molecular therapy for the treatment of hepatocellular carcinomaT F Greten, F Korangy, M P Manns, et al.International Journal of Immunopharmacology|July 1, 1995
The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxideT F Greten, A Eigler, B Sinha, et al.Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?R T Reilly, L A Emens, E M JaffeeEndocrine-Related Cancer|March 25, 2005
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunityL A Emens, R T Reilly, E M JaffeeCurrent Protocols in Immunology|April 25, 2008
Monitoring antigen-specific T cells using MHC-Ig dimersJ P Schneck, J E Slansky, S M O'Herrin, et al.Deutsche Medizinische Wochenschrift (1946)|October 17, 2008
[Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]S Ciesek, T Kirchhoff, M Niehaus, et al.European Journal of Pharmacology|February 26, 1997
Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agentsB Siegmund, A Eigler, J Moeller, et al.Scandinavian Journal of Immunology|February 1, 1997
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesisA Eigler, T F Greten, B Sinha, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2013
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trialsO E Rahma, A Duffy, D J Liewehr, et al.Research in Immunology|June 17, 1998
Nitric oxide downregulates tumour necrosis factor in mRNA in RAW 264.7 cellsB Sinha, A Eigler, K H Baumann, et al.Pageof 7